IDEX Corporation provided earnings guidance for the year 2022. Full year 2022 organic sales growth is projected to be approximately 10%, with a 9% to 10% organic sales increase in the third quarter of 2022 versus the prior year period. The Company expects full year 2022 reported EPS attributable to IDEX of $7.19 to $7.29 (adjusted EPS attributable to IDEX of $7.88 to $7.98) and third quarter 2022 reported EPS attributable to IDEX of $1.80 to $1.85 (adjusted EPS attributable to IDEX of $1.98 to $2.03).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
218 USD | +0.40% | -2.77% | +0.41% |
May. 16 | IDEX Biometrics Completes Upsized NOK55 Million Share Placement | MT |
May. 08 | Declaration of Voting Results by IDEX Corporation | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.41% | 16.5B | |
-4.33% | 14.04B | |
-6.12% | 5.13B | |
+2.47% | 4.56B | |
+7.43% | 3.14B | |
+31.53% | 1.94B | |
+91.01% | 1.63B | |
+0.75% | 1.22B | |
+18.66% | 1.02B | |
-6.56% | 870M |
- Stock Market
- Equities
- IEX Stock
- News IDEX Corporation
- IDEX Corporation Provides Earnings Guidance for the Year 2022